Wednesday, February 10, 2010, 8:43am EST - Canadian Markets open in 47 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Bruker BioSciences Corp. (BRKR)

 On Feb 9: 12.84 USD   0.00 (0.00%)  
MORE ON BRKR
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Bruker Corporation (NasdaqNM:BRKR) Delayed quote dataEdit
Last Trade: 12.84 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 12.84
Open: N/A
Bid: 11.68 x 100
Ask: 13.30 x 100
1y Target Est: 13.67
Day's Range: N/A - N/A
52wk Range: 3.47 - 13.90
Volume: 0
Avg Vol (3m): 577,011
Market Cap: 2.11B
P/E (ttm): 49.96
EPS (ttm): 0.26
Div & Yield: N/A (N/A%)
Bruker BioSciences Corp. (BRKR)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add BRKR to Portfolio   Download Data

HEADLINES
• BRUKER CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Fri, Feb 5)
• Bruker Announces Management Promotions and Strong Fourth Quarter 2009 Preliminary Operating Results
Business Wire (Thu, Feb 4)
• [video] Bruker Corp: One Minute Trade
at TheStreet.com (Mon, Feb 1)
• Bruker Appoints Urban Faeh as President of its Bruker Optics Division
Business Wire (Tue, Jan 12)
• Bruker Announces Advancement to Phase IIIb of the DHS Autonomous Rapid Facility Chemical Agent Monitor Program
Business Wire (Mon, Jan 11)
• Bruker Corporation to Present at 28th J.P. Morgan Healthcare Conference
Business Wire (Fri, Jan 8)
• Bruker rises on flurry of stimulus orders
at bizjournals.com (Thu, Jan 7)
• Bruker Announces Over 100 Systems Orders Received in the Second Half of 2009 from Global Stimulus Programs
Business Wire (Thu, Jan 7)
• Avoiding 'Green' Investment Scams
at Seeking Alpha (Thu, Jan 7)
• How to Avoid Green Investment Scams
at Motley Fool (Wed, Jan 6)
• Bruker Announces Framework Agreement for EPR e-scan Beer Analyzers to Enable New Levels of Quality and Process Control at SABMillers Latin American Br
Business Wire (Tue, Jan 5)
More Headlines for BRKR...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 2.3
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Bruker BioSciences Corporation engages in the design, manufacture, service, and marketing of analytical and life science systems and associated products worldwide.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices